FilingReader Intelligence
Sequent Scientific reports 13% revenue growth, merger progressing
August 14, 2025 at 05:00 AM UTC•By FilingReader AI
Sequent Scientific reported Q1 FY26 revenues of INR4,414 million, up 13.1% year-on-year, with pre-ESOP EBITDA reaching INR602 million. API revenue grew 14%.
The strategic merger with Viyash Group advances with NCLT shareholder and creditor meetings scheduled for August 30, 2025. Viyash's Q1 FY26 revenue grew 4% to INR353 crores.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
News Alerts
Get instant email alerts when Sequent Scientific publishes news
Free account required • Unsubscribe anytime